Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Institutional Investors in Europe

Institutional Investors in Europe

posted on Feb 05, 2009 09:49AM

Anyone recall RG talking about soliciting institutional investors in "Europe" a while back?

It may be possible that this German ruling was connected somehow(?)

Share
New Message
Please login to post a reply